AltheaDx: Derek Maetzold

AltheaDx has appointed Derek Maetzold to its board. He is the founder and CEO of Castle Biosciences and previously was at Encysive Pharmaceuticals, Amylin Pharmaceuticals, Sandoz, and Schering-Plough, where he held leadership roles. San Diego-based AltheaDx develops molecular diagnostic tests for pharmacogenomics applications with a focus on mental health.